GANCICLOVIR SODIUM

GANCICLOVIR SODIUM was reported 10707 times

GANCICLOVIR SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENCEPHALITIS CYTOMEGALOVIRUS 176 0.4018
1 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
2 IMMUNE RECOVERY UVEITIS 21 0.3621
3 OESOPHAGOPLEURAL FISTULA 11 0.3438
4 CYTOMEGALOVIRUS MYOCARDITIS 11 0.3333
5 CYTOMEGALOVIRUS SYNDROME 46 0.2788
6 SMOOTH MUSCLE CELL NEOPLASM 108 0.2584
7 RETINITIS VIRAL 28 0.2314
8 FLAVOBACTERIUM INFECTION 9 0.2045
9 CYTOMEGALOVIRUS GASTRITIS 40 0.1581
10 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 45 0.1510
11 NECROTISING HERPETIC RETINOPATHY 10 0.1351
12 DISSEMINATED CYTOMEGALOVIRAL INFECTION 28 0.1296
13 CYTOMEGALOVIRUS GASTROENTERITIS 27 0.1250
14 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 7 0.1186
15 CYTOMEGALOVIRUS DUODENITIS 8 0.1143
16 INTRACRANIAL INFECTION 14 0.1120
17 CYTOMEGALOVIRUS CHORIORETINITIS 217 0.1112
18 AUTOIMMUNE PANCYTOPENIA 10 0.1099
19 CYTOMEGALOVIRUS OESOPHAGITIS 40 0.1087
20 PNEUMONIA CYTOMEGALOVIRAL 199 0.1024
21 CYTOMEGALOVIRUS VIRAEMIA 444 0.0997
22 EPSTEIN-BARR VIRAEMIA 107 0.0965
23 BK POLYOMAVIRUS TEST POSITIVE 9 0.0938
24 CYTOMEGALOVIRUS INFECTION REACTIVATION 414 0.0936
25 CYTOMEGALOVIRUS ANTIGEN POSITIVE 17 0.0929
26 CYTOMEGALOVIRUS COLITIS 212 0.0921
27 ACANTHAMOEBA INFECTION 16 0.0851
28 VIRAL UVEITIS 8 0.0825
29 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 15 0.0802
30 DRUG RESISTANCE MUTATION 14 0.0787
31 MYOCARDIAL CALCIFICATION 9 0.0769
32 CYTOMEGALOVIRUS INFECTION 1276 0.0767
33 ADENOVIRUS REACTIVATION 11 0.0764
34 CYTOMEGALOVIRUS ENTERITIS 27 0.0758
35 CYTOMEGALOVIRUS HEPATITIS 26 0.0734
36 TRACTIONAL RETINAL DETACHMENT 8 0.0721
37 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 11 0.0719
38 VIRAL HAEMORRHAGIC CYSTITIS 50 0.0702
39 CYTOMEGALOVIRUS ENTEROCOLITIS 53 0.0688
40 NECROTISING RETINITIS 41 0.0641
41 GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0615
42 SELECTIVE IGA IMMUNODEFICIENCY 9 0.0612
43 HUMAN HERPESVIRUS 8 INFECTION 37 0.0608
44 CYTOMEGALOVIRUS TEST POSITIVE 108 0.0605
45 GASTROINTESTINAL MUCORMYCOSIS 10 0.0599
46 PARVOVIRUS INFECTION 24 0.0594
47 RHEGMATOGENOUS RETINAL DETACHMENT 12 0.0574
48 INFECTED NEOPLASM 14 0.0562
49 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 79 0.0559
50 PARVOVIRUS B19 INFECTION 49 0.0547
51 SCEDOSPORIUM INFECTION 38 0.0538
52 BK VIRUS INFECTION 180 0.0533
53 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 268 0.0526
54 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 69 0.0524
55 BRONCHIOLITIS OBLITERANS SYNDROME 9 0.0514
56 CYSTITIS HAEMORRHAGIC 205 0.0508
57 IDIOPATHIC PNEUMONIA SYNDROME 15 0.0503
58 BRONCHOALVEOLAR LAVAGE ABNORMAL 10 0.0481
59 ADENOVIRAL HEPATITIS 11 0.0468
60 UREAPLASMA INFECTION 19 0.0466
61 HUMAN HERPESVIRUS 6 ENCEPHALITIS 13 0.0458
62 COMPLICATIONS OF TRANSPLANTED LUNG 14 0.0456
63 BACTERIAL TRANSLOCATION 14 0.0442
64 ADENOVIRAL HAEMORRHAGIC CYSTITIS 9 0.0433
65 FUSARIUM INFECTION 30 0.0429
66 GLOMERULOSCLEROSIS 27 0.0427
67 EPSTEIN-BARR VIRUS INFECTION 263 0.0421
68 CONFABULATION 11 0.0415
69 HERPES SIMPLEX TEST POSITIVE 8 0.0402
70 ENTEROCOLITIS VIRAL 12 0.0395
71 ASPERGILLOSIS 51 0.0390
72 FUNGAL SEPSIS 32 0.0385
73 LUNG TRANSPLANT REJECTION 25 0.0379
74 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 67 0.0379
75 GRAFT VERSUS HOST DISEASE IN SKIN 81 0.0367
76 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 26 0.0362
77 URINARY TRACT INFLAMMATION 13 0.0361
78 COMPLICATIONS OF TRANSPLANTED LIVER 13 0.0361
79 DISSEMINATED MUCORMYCOSIS 14 0.0355
80 PULMONARY NECROSIS 12 0.0352
81 ENGRAFT FAILURE 10 0.0348
82 ADENOVIRUS INFECTION 101 0.0348
83 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 96 0.0347
84 PATHOGEN RESISTANCE 310 0.0340
85 KERATITIS FUNGAL 7 0.0337
86 GRAFT VERSUS HOST DISEASE IN LUNG 16 0.0335
87 PNEUMOCYSTIS JIROVECII INFECTION 40 0.0335
88 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 71 0.0333
89 GRAFT VERSUS HOST DISEASE 235 0.0326
90 BLOOD BETA-D-GLUCAN INCREASED 10 0.0326
91 STENOTROPHOMONAS INFECTION 44 0.0324
92 ACUTE ON CHRONIC LIVER FAILURE 7 0.0324
93 BLADDER HYPERTROPHY 14 0.0317
94 ACUTE GRAFT VERSUS HOST DISEASE 145 0.0316
95 BURKHOLDERIA CEPACIA COMPLEX INFECTION 9 0.0315
96 GLOMERULONEPHROPATHY 8 0.0312
97 CONDUCTIVE DEAFNESS 10 0.0312
98 RETINAL ISCHAEMIA 19 0.0311
99 INCISION SITE PAIN 36 0.0306
100 RETINAL SCAR 14 0.0304
101 CD4 LYMPHOCYTES INCREASED 7 0.0300
102 RED BLOOD CELLS URINE POSITIVE 29 0.0300
103 TRANSPLANT REJECTION 240 0.0299
104 CEREBRAL ASPERGILLOSIS 18 0.0293
105 MORAXELLA INFECTION 8 0.0292
106 INFECTION REACTIVATION 33 0.0288
107 TOXOPLASMOSIS 31 0.0287
108 DRUG RESISTANCE 738 0.0287
109 EYE INFECTION FUNGAL 11 0.0284
110 ENCEPHALITIS HERPES 14 0.0283
111 ACINETOBACTER INFECTION 31 0.0283
112 GRAFT DYSFUNCTION 8 0.0281
113 OPHTHALMIC HERPES SIMPLEX 16 0.0278
114 RED BLOOD CELL SCHISTOCYTES PRESENT 9 0.0278
115 HUMAN POLYOMAVIRUS INFECTION 14 0.0264
116 INTUSSUSCEPTION 25 0.0262
117 ASPERGILLUS TEST POSITIVE 8 0.0260
118 CENTRAL NERVOUS SYSTEM NECROSIS 7 0.0255
119 CEREBRAL TOXOPLASMOSIS 23 0.0246
120 HUMAN HERPESVIRUS 6 INFECTION 46 0.0243
121 ENTEROCOCCAL INFECTION 117 0.0242
122 TRANSPLANT DYSFUNCTION 43 0.0241
123 ENTEROCOCCAL BACTERAEMIA 25 0.0236
124 POLYOMAVIRUS VIRAEMIA 25 0.0235
125 ADRENAL MASS 19 0.0229
126 SEPTIC EMBOLUS 19 0.0228
127 NEPHROPATHY TOXIC 256 0.0228
128 ASPERGILLUS INFECTION 148 0.0225
129 CONGENITAL APLASIA 7 0.0225
130 GRAFT LOSS 16 0.0221
131 CHRONIC GRAFT VERSUS HOST DISEASE 78 0.0216
132 IMMUNE RECONSTITUTION SYNDROME 27 0.0209
133 CYSTITIS VIRAL 8 0.0209
134 THROMBOTIC MICROANGIOPATHY 201 0.0206
135 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 150 0.0200
136 KLEBSIELLA INFECTION 101 0.0200
137 BRAIN COMPRESSION 8 0.0200
138 PHARYNGEAL ABSCESS 10 0.0199
139 PSEUDOMONAL BACTERAEMIA 17 0.0199
140 MUCORMYCOSIS 51 0.0196
141 GRAFT VERSUS HOST DISEASE IN LIVER 14 0.0196
142 VIRAEMIA 27 0.0195
143 LIVER TRANSPLANT REJECTION 35 0.0195
144 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0194
145 RETINAL TOXICITY 20 0.0194
146 MACULAR FIBROSIS 13 0.0192
147 TRANSPLANT FAILURE 47 0.0192
148 RESPIRATORY TRACT INFECTION FUNGAL 10 0.0189
149 BRONCHOPLEURAL FISTULA 7 0.0186
150 ENGRAFTMENT SYNDROME 11 0.0186
151 KIDNEY TRANSPLANT REJECTION 89 0.0185
152 COMPLICATIONS OF TRANSPLANTED KIDNEY 42 0.0185
153 ECZEMA NUMMULAR 9 0.0184
154 HERPES SIMPLEX REACTIVATION 7 0.0184
155 INFECTION IN AN IMMUNOCOMPROMISED HOST 13 0.0181
156 LOWER RESPIRATORY TRACT INFECTION FUNGAL 7 0.0180
157 GASTRIC FISTULA 8 0.0179
158 CHRONIC ALLOGRAFT NEPHROPATHY 14 0.0179
159 T-LYMPHOCYTE COUNT DECREASED 12 0.0176
160 MARROW HYPERPLASIA 12 0.0176
161 MENINGITIS VIRAL 24 0.0175
162 DISSEMINATED ASPERGILLOSIS 8 0.0169
163 TRACHEOBRONCHITIS 13 0.0169
164 DELAYED GRAFT FUNCTION 12 0.0169
165 STRONGYLOIDIASIS 27 0.0167
166 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 39 0.0166
167 BACTERIAL SEPSIS 54 0.0166
168 PNEUMOCYSTIS JIROVECII PNEUMONIA 166 0.0165
169 GENITAL LESION 7 0.0165
170 ENCEPHALITIS VIRAL 20 0.0164
171 CITROBACTER INFECTION 7 0.0163
172 PNEUMONIA PSEUDOMONAL 25 0.0163
173 BRONCHOPULMONARY ASPERGILLOSIS 126 0.0162
174 RENAL TRANSPLANT FAILURE 16 0.0162
175 KIDNEY FIBROSIS 28 0.0161
176 OESOPHAGITIS ULCERATIVE 11 0.0161
177 EPSTEIN-BARR VIRUS TEST POSITIVE 10 0.0158
178 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 52 0.0157
179 DIFFUSE ALVEOLAR DAMAGE 18 0.0157
180 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 25 0.0156
181 HYPHAEMA 8 0.0153
182 METAPNEUMOVIRUS INFECTION 12 0.0153
183 MULTIPLE ORGAN DYSFUNCTION SYNDROME 432 0.0152
184 OBLITERATIVE BRONCHIOLITIS 20 0.0152
185 BONE MARROW TOXICITY 18 0.0152
186 APLASIA PURE RED CELL 51 0.0148
187 FUNGAEMIA 23 0.0146
188 SYSTEMIC MYCOSIS 17 0.0146
189 VARICELLA ZOSTER VIRUS INFECTION 30 0.0145
190 BRAIN HERNIATION 43 0.0144
191 PULMONARY MYCOSIS 11 0.0141
192 VIRAL LOAD INCREASED 54 0.0139
193 LYMPHOCELE 9 0.0136
194 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 8 0.0135
195 ALVEOLAR PROTEINOSIS 8 0.0135
196 NEUROLOGICAL DECOMPENSATION 31 0.0134
197 HYPERPLASIA 12 0.0133
198 CRYPTOSPORIDIOSIS INFECTION 7 0.0133
199 RETINITIS 23 0.0133
200 BOTULISM 11 0.0133
201 SUBCUTANEOUS EMPHYSEMA 13 0.0132
202 CAMPYLOBACTER INFECTION 11 0.0132
203 VENOOCCLUSIVE LIVER DISEASE 65 0.0131
204 BRAIN ABSCESS 33 0.0130
205 STREPTOCOCCAL BACTERAEMIA 14 0.0129
206 VENOOCCLUSIVE DISEASE 32 0.0128
207 PNEUMONIA CRYPTOCOCCAL 12 0.0127
208 INTRACRANIAL MASS 12 0.0127
209 ABDOMINAL COMPARTMENT SYNDROME 8 0.0126
210 LUNG INFECTION PSEUDOMONAL 7 0.0125
211 RENAL TUBULAR INJURY 15 0.0123
212 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 61 0.0122
213 NEPHROGENIC DIABETES INSIPIDUS 14 0.0121
214 HYPOPROTEINAEMIA 23 0.0121
215 PNEUMONIA KLEBSIELLA 22 0.0120
216 VIRAL MUTATION IDENTIFIED 44 0.0119
217 ACTINIC KERATOSIS 31 0.0119
218 GRAFT COMPLICATION 7 0.0119
219 RETINAL VASCULITIS 14 0.0118
220 COMPUTERISED TOMOGRAM THORAX ABNORMAL 8 0.0116
221 KLEBSIELLA BACTERAEMIA 11 0.0116
222 NEUTROPENIC INFECTION 11 0.0115
223 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 9 0.0114
224 PSEUDOMONAS INFECTION 98 0.0114
225 RENAL TUBULAR ATROPHY 10 0.0113
226 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 30 0.0113
227 URETERIC STENOSIS 9 0.0112
228 HERPES ZOSTER DISSEMINATED 9 0.0112
229 PROTEUS INFECTION 8 0.0111
230 CORNEAL PERFORATION 7 0.0111
231 PNEUMOMEDIASTINUM 20 0.0111
232 PNEUMONIA STREPTOCOCCAL 12 0.0109
233 OSMOTIC DEMYELINATION SYNDROME 8 0.0108
234 STAPHYLOCOCCAL SEPSIS 53 0.0107
235 APLASTIC ANAEMIA 56 0.0107
236 KLEBSIELLA SEPSIS 12 0.0106
237 MULTIPLE-DRUG RESISTANCE 33 0.0106
238 LYMPHADENOPATHY MEDIASTINAL 20 0.0104
239 HISTIOCYTOSIS HAEMATOPHAGIC 31 0.0104
240 ARTERIAL RUPTURE 8 0.0104
241 PULMONARY CAVITATION 9 0.0103
242 RENAL TUBULAR DISORDER 29 0.0103
243 SUPERINFECTION BACTERIAL 8 0.0101
244 PANCYTOPENIA 561 0.0100
245 LUNG ABSCESS 21 0.0100
246 PNEUMOCYSTIS JIROVECI PNEUMONIA 22 0.0099
247 LYMPHOPROLIFERATIVE DISORDER 29 0.0099
248 CEREBRAL ARTERY EMBOLISM 12 0.0098
249 HYPOGAMMAGLOBULINAEMIA 64 0.0097
250 OPPORTUNISTIC INFECTION 18 0.0097
251 HYPERLACTACIDAEMIA 26 0.0097
252 ESCHERICHIA SEPSIS 28 0.0097
253 MICROANGIOPATHY 9 0.0096
254 LEUKAEMIA RECURRENT 16 0.0095
255 ESCHERICHIA BACTERAEMIA 22 0.0093
256 ENCEPHALITIS 62 0.0090
257 IMMUNE THROMBOCYTOPENIA 41 0.0089
258 ENDOCARDITIS BACTERIAL 7 0.0089
259 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
260 LYMPHOPENIA 124 0.0088
261 SYSTEMIC CANDIDA 22 0.0088
262 ENTEROCOCCAL SEPSIS 7 0.0086
263 OPTIC ATROPHY 14 0.0086
264 DYSBIOSIS 7 0.0085
265 BILE DUCT STENOSIS 10 0.0083
266 CONTINUOUS HAEMODIAFILTRATION 8 0.0082
267 BICYTOPENIA 16 0.0082
268 PNEUMONIA VIRAL 26 0.0081
269 OESOPHAGEAL CANDIDIASIS 32 0.0080
270 STEROID DIABETES 12 0.0080
271 CENTRAL NERVOUS SYSTEM LYMPHOMA 11 0.0080
272 PNEUMONIA BACTERIAL 73 0.0079
273 ILEAL ULCER 8 0.0079
274 MYCOBACTERIUM AVIUM COMPLEX INFECTION 21 0.0078
275 LEUKOPENIA 391 0.0078
276 HAEMOLYTIC URAEMIC SYNDROME 18 0.0078
277 LARGE INTESTINAL ULCER 21 0.0077
278 ENTEROBACTER INFECTION 13 0.0077
279 RETINAL DEGENERATION 10 0.0077
280 GASTROINTESTINAL VIRAL INFECTION 8 0.0077
281 PULMONARY HAEMORRHAGE 60 0.0077
282 SQUAMOUS CELL CARCINOMA OF SKIN 46 0.0076
283 CYTOPENIA 93 0.0076
284 CLOSTRIDIUM DIFFICILE COLITIS 80 0.0075
285 JC VIRUS INFECTION 12 0.0075
286 ABDOMINAL INFECTION 19 0.0074
287 APRAXIA 11 0.0074
288 URETERIC OBSTRUCTION 10 0.0073
289 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 28 0.0073
290 SUBRETINAL FLUID 8 0.0073
291 BONE MARROW FAILURE 148 0.0073
292 VITREOUS HAEMORRHAGE 20 0.0072
293 MULTI-ORGAN FAILURE 124 0.0072
294 OLIGURIA 44 0.0071
295 HEPATOSPLENOMEGALY 18 0.0070
296 CD4 LYMPHOCYTES DECREASED 15 0.0070
297 PLATELET TRANSFUSION 9 0.0070
298 ACUTE MYELOID LEUKAEMIA RECURRENT 15 0.0070
299 PSEUDOMONAL SEPSIS 12 0.0068
300 RESTRICTIVE PULMONARY DISEASE 8 0.0068
301 HERPES SIMPLEX 44 0.0068
302 GASTROINTESTINAL ULCER 15 0.0068
303 CRYPTOCOCCOSIS 11 0.0067
304 HEART TRANSPLANT REJECTION 7 0.0067
305 CLOSTRIDIUM COLITIS 8 0.0066
306 PNEUMONIA FUNGAL 26 0.0066
307 SEPTIC SHOCK 286 0.0066
308 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
309 HAEMORRHAGE INTRACRANIAL 98 0.0065
310 MYELOSUPPRESSION 234 0.0065
311 DISSEMINATED INTRAVASCULAR COAGULATION 91 0.0065
312 GENERALISED OEDEMA 80 0.0065
313 ACUTE RESPIRATORY DISTRESS SYNDROME 114 0.0064
314 ADENOCARCINOMA OF COLON 12 0.0064
315 END STAGE RENAL DISEASE 116 0.0064
316 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 7 0.0063
317 INTRA-ABDOMINAL HAEMORRHAGE 15 0.0063
318 LIP HAEMORRHAGE 8 0.0063
319 RETINAL OEDEMA 12 0.0063
320 PSEUDOMEMBRANOUS COLITIS 14 0.0063
321 NOROVIRUS INFECTION 9 0.0062
322 LEUKOENCEPHALOPATHY 23 0.0062
323 CENTRAL NERVOUS SYSTEM INFECTION 7 0.0061
324 MACULAR OEDEMA 34 0.0061
325 GENE MUTATION 12 0.0061
326 LYMPHOCYTOSIS 13 0.0060
327 IMMUNE-MEDIATED LUNG DISEASE 11 0.0060
328 GASTROINTESTINAL STROMAL TUMOUR 16 0.0060
329 HYPERAMMONAEMIA 30 0.0060
330 BILIRUBIN CONJUGATED INCREASED 14 0.0060
331 BACTERAEMIA 71 0.0060
332 HEPATITIS CHOLESTATIC 36 0.0060
333 DEVICE RELATED SEPSIS 12 0.0060
334 NOSOCOMIAL INFECTION 13 0.0059
335 RESPIRATORY DISTRESS 162 0.0059
336 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 56 0.0059
337 NOCARDIOSIS 15 0.0059
338 CORNEAL OPACITY 8 0.0059
339 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 7 0.0058
340 RESPIRATORY FAILURE 423 0.0058
341 STAPHYLOCOCCAL BACTERAEMIA 25 0.0057
342 MENINGITIS CRYPTOCOCCAL 10 0.0057
343 IMPRISONMENT 10 0.0057
344 RETINAL DETACHMENT 52 0.0057
345 PROTEIN URINE PRESENT 28 0.0056
346 ENTEROCOLITIS 32 0.0055
347 URINARY TRACT INFECTION BACTERIAL 14 0.0055
348 OESOPHAGEAL ULCER 21 0.0055
349 ORGANISING PNEUMONIA 27 0.0054
350 NORMOCYTIC ANAEMIA 8 0.0054
351 QUADRIPARESIS 9 0.0054
352 ENCEPHALITIS AUTOIMMUNE 7 0.0053
353 CYSTOID MACULAR OEDEMA 10 0.0053
354 SECONDARY ADRENOCORTICAL INSUFFICIENCY 8 0.0053
355 HYPOALBUMINAEMIA 41 0.0053
356 MECHANICAL VENTILATION 10 0.0053
357 LIVER ABSCESS 17 0.0052
358 CANDIDA INFECTION 87 0.0051
359 GASTROINTESTINAL NECROSIS 15 0.0051
360 HAEMORRHAGE URINARY TRACT 13 0.0051
361 GASTRIC ULCER 97 0.0051
362 PNEUMONIA STAPHYLOCOCCAL 10 0.0051
363 CACHEXIA 26 0.0050
364 HISTOPLASMOSIS DISSEMINATED 8 0.0050
365 INTESTINAL ULCER 8 0.0050
366 CANDIDIASIS 20 0.0050
367 PULMONARY TUBERCULOSIS 21 0.0049
368 DUODENITIS 15 0.0049
369 PNEUMOPERITONEUM 9 0.0049
370 BRAIN DEATH 15 0.0048
371 PULMONARY ALVEOLAR HAEMORRHAGE 27 0.0048
372 RETINAL HAEMORRHAGE 34 0.0048
373 HYDROCEPHALUS 26 0.0048
374 LUNG INFILTRATION 42 0.0048
375 HAEMODYNAMIC INSTABILITY 36 0.0047
376 HYPERCAPNIA 14 0.0046
377 HAEMATOTOXICITY 44 0.0046
378 INFECTIOUS PLEURAL EFFUSION 7 0.0046
379 MULTI-ORGAN DISORDER 9 0.0046
380 NEUTROPENIA 614 0.0045
381 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 247 0.0045
382 COMA SCALE ABNORMAL 13 0.0045
383 ORGAN FAILURE 18 0.0045
384 ESCHERICHIA INFECTION 36 0.0044
385 ENTERITIS 28 0.0044
386 SOFT TISSUE INFECTION 8 0.0044
387 LYMPHOCYTE COUNT DECREASED 77 0.0044
388 CAPILLARY LEAK SYNDROME 9 0.0043
389 HYPERBILIRUBINAEMIA 45 0.0043
390 VITRITIS 8 0.0043
391 BONE MARROW DISORDER 13 0.0043
392 NEUTROPHIL COUNT INCREASED 44 0.0043
393 MALNUTRITION 48 0.0043
394 RENAL IMPAIRMENT 360 0.0043
395 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
396 SPLENOMEGALY 49 0.0042
397 CEREBRAL HAEMATOMA 14 0.0042
398 TOXIC ENCEPHALOPATHY 21 0.0041
399 HYPERURICAEMIA 17 0.0041
400 RENAL TUBULAR ACIDOSIS 9 0.0041
401 LUNG INFECTION 64 0.0041
402 IRIDOCYCLITIS 13 0.0041
403 PYELONEPHRITIS ACUTE 8 0.0041
404 HAEMODIALYSIS 34 0.0040
405 PARESIS 9 0.0040
406 STEM CELL TRANSPLANT 10 0.0040
407 RENAL TUBULAR NECROSIS 39 0.0040
408 BRAIN OEDEMA 50 0.0040
409 HISTOPLASMOSIS 7 0.0040
410 ACUTE RESPIRATORY FAILURE 76 0.0039
411 BLOOD UREA INCREASED 66 0.0039
412 OTITIS MEDIA 13 0.0039
413 LUNG CONSOLIDATION 11 0.0039
414 SHOCK HAEMORRHAGIC 32 0.0039
415 FIBROSIS 12 0.0039
416 DIFFUSE LARGE B-CELL LYMPHOMA 30 0.0039
417 SEPSIS 432 0.0039
418 NEUTROPENIC COLITIS 8 0.0039
419 BLOOD HIV RNA INCREASED 7 0.0039
420 CEREBRAL VENOUS THROMBOSIS 7 0.0039
421 LUNG OPACITY 10 0.0038
422 VASCULAR DEVICE INFECTION 17 0.0037
423 HYPERTRANSAMINASAEMIA 26 0.0037
424 CHOLANGITIS 23 0.0037
425 ELECTROLYTE IMBALANCE 43 0.0037
426 TUBULOINTERSTITIAL NEPHRITIS 69 0.0037
427 TACHYPNOEA 50 0.0037
428 ULCERATIVE KERATITIS 10 0.0036
429 CORNEAL DISORDER 8 0.0036
430 BACTERIAL INFECTION 68 0.0036
431 NEPHROGENIC SYSTEMIC FIBROSIS 11 0.0036
432 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 30 0.0036
433 HYPOMAGNESAEMIA 50 0.0036
434 MUCOSAL INFLAMMATION 94 0.0036
435 APLASIA 7 0.0036
436 BRONCHIECTASIS 24 0.0036
437 AGRANULOCYTOSIS 66 0.0035
438 THROMBOCYTOPENIA 396 0.0035
439 B-CELL LYMPHOMA 12 0.0035
440 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
441 GUILLAIN-BARRE SYNDROME 17 0.0035
442 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
443 RETINOPATHY 13 0.0035
444 ASCITES 102 0.0035
445 PNEUMOTHORAX 55 0.0035
446 HEPATITIS B REACTIVATION 11 0.0035
447 GASTROINTESTINAL INFECTION 31 0.0035
448 HEPATIC NECROSIS 13 0.0034
449 DIARRHOEA HAEMORRHAGIC 32 0.0034
450 IMMUNOSUPPRESSION 30 0.0034
451 HYPOPHOSPHATAEMIA 25 0.0034
452 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 20 0.0034
453 PNEUMONITIS 91 0.0033
454 CHOLESTASIS 64 0.0033
455 AUTOIMMUNE HEPATITIS 23 0.0033
456 HERPES VIRUS INFECTION 19 0.0033
457 HEPATIC FUNCTION ABNORMAL 123 0.0033
458 CLONUS 9 0.0033
459 HEPATIC FAILURE 99 0.0033
460 BLOOD ALBUMIN DECREASED 26 0.0033
461 HYPERVOLAEMIA 16 0.0032
462 COLITIS 121 0.0032
463 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
464 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19 0.0031
465 LARGE INTESTINAL HAEMORRHAGE 7 0.0031
466 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 8 0.0031
467 VENTRICULAR DYSFUNCTION 8 0.0031
468 RETINAL DISORDER 8 0.0031
469 HYDRONEPHROSIS 23 0.0031
470 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
471 FUNGAL INFECTION 101 0.0030
472 LIVER TRANSPLANT 11 0.0030
473 ENCEPHALOPATHY 74 0.0030
474 BLOOD CULTURE POSITIVE 9 0.0030
475 SHOCK 68 0.0030
476 CLOSTRIDIAL INFECTION 10 0.0030
477 CARDIAC DYSFUNCTION 11 0.0030
478 BRONCHOPNEUMONIA 10 0.0029
479 PLEURAL EFFUSION 177 0.0029
480 HYPERTRIGLYCERIDAEMIA 17 0.0029
481 LYMPHADENITIS 7 0.0029
482 SUSPECTED OFF LABEL USE 13 0.0029
483 SERUM SICKNESS 8 0.0029
484 GLOMERULONEPHRITIS 7 0.0029
485 HEPATOMEGALY 28 0.0028
486 HAEMOLYSIS 22 0.0028
487 RESPIRATORY ACIDOSIS 11 0.0028
488 HEPATITIS 71 0.0028
489 FEBRILE NEUTROPENIA 182 0.0027
490 LARGE INTESTINE PERFORATION 19 0.0027
491 TUMOUR LYSIS SYNDROME 24 0.0027
492 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
493 GASTROINTESTINAL TOXICITY 13 0.0027
494 ATAXIA 32 0.0027
495 ATYPICAL PNEUMONIA 8 0.0027
496 WOUND DEHISCENCE 9 0.0027
497 KERATITIS 8 0.0026
498 NEPHROTIC SYNDROME 18 0.0026
499 INTERSTITIAL LUNG DISEASE 127 0.0026
500 HEPATIC FIBROSIS 9 0.0026
501 ACIDOSIS 20 0.0026
502 DERMATITIS EXFOLIATIVE 13 0.0026
503 PORTAL HYPERTENSION 8 0.0026
504 UVEITIS 35 0.0026
505 INTESTINAL ISCHAEMIA 14 0.0025
506 DEVICE RELATED INFECTION 39 0.0025
507 CEREBRAL ISCHAEMIA 13 0.0025
508 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
509 HYPERLIPIDAEMIA 30 0.0025
510 ENDOPHTHALMITIS 15 0.0025
511 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
512 ENDOTRACHEAL INTUBATION 7 0.0025
513 THERAPY NON-RESPONDER 112 0.0025
514 STUPOR 8 0.0025
515 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0025
516 BLOOD CREATININE INCREASED 160 0.0024
517 NYSTAGMUS 13 0.0024
518 NEUROLOGICAL SYMPTOM 14 0.0024
519 ANURIA 21 0.0024
520 DRUG LEVEL INCREASED 40 0.0024
521 HYPERNATRAEMIA 12 0.0024
522 HIGH DENSITY LIPOPROTEIN DECREASED 8 0.0024
523 RENAL FAILURE ACUTE 101 0.0024
524 CEREBRAL HAEMORRHAGE 85 0.0024
525 HYPERPYREXIA 10 0.0024
526 ODYNOPHAGIA 14 0.0023
527 HAEMOLYTIC ANAEMIA 21 0.0023
528 PRODUCT USE IN UNAPPROVED INDICATION 575 0.0023
529 INTESTINAL PERFORATION 26 0.0023
530 FAILURE TO THRIVE 12 0.0023
531 BASAL CELL CARCINOMA 36 0.0023
532 RENAL FAILURE 306 0.0023
533 HEMIPARESIS 39 0.0023
534 TONSILLITIS 12 0.0023
535 BLOOD BILIRUBIN INCREASED 62 0.0023
536 ASPIRATION 25 0.0023
537 GRANULOCYTOPENIA 13 0.0023
538 ORAL CANDIDIASIS 30 0.0023
539 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0023
540 DEPRESSIVE SYMPTOM 8 0.0023
541 HYPOKALAEMIA 104 0.0023
542 MENINGITIS 15 0.0022
543 LYMPHADENOPATHY 79 0.0022
544 NEUROTOXICITY 39 0.0022
545 HYPOVOLAEMIA 13 0.0022
546 METABOLIC ACIDOSIS 71 0.0022
547 ABDOMINAL TENDERNESS 11 0.0022
548 ACUTE KIDNEY INJURY 338 0.0022
549 MYOPATHY 19 0.0022
550 HYPERKALAEMIA 76 0.0022
551 LUNG DISORDER 106 0.0022
552 HYPOXIA 76 0.0022
553 NECROSIS 12 0.0022
554 OFF LABEL USE 1871 0.0021
555 STAPHYLOCOCCAL INFECTION 70 0.0021
556 AUTOIMMUNE THYROIDITIS 8 0.0021
557 HEPATOTOXICITY 47 0.0021
558 NEUTROPENIC SEPSIS 15 0.0021
559 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
560 C-REACTIVE PROTEIN INCREASED 76 0.0021
561 BLOOD LACTIC ACID INCREASED 11 0.0021
562 HYPOVOLAEMIC SHOCK 10 0.0021
563 ATELECTASIS 20 0.0021
564 RALES 12 0.0021
565 VENOUS THROMBOSIS 8 0.0020
566 PERICARDIAL EFFUSION 47 0.0020
567 COVID-19 PNEUMONIA 24 0.0020
568 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
569 TREATMENT FAILURE 168 0.0020
570 ILEUS PARALYTIC 9 0.0020
571 EOSINOPHILIA 35 0.0020
572 FACIAL PARALYSIS 17 0.0020
573 PULMONARY TOXICITY 14 0.0020
574 INTRACRANIAL PRESSURE INCREASED 11 0.0020
575 PYELONEPHRITIS 17 0.0020
576 HEPATIC ENCEPHALOPATHY 18 0.0019
577 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
578 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
579 RASH MACULO-PAPULAR 42 0.0019
580 PERITONITIS 39 0.0019
581 PERIPHERAL SENSORY NEUROPATHY 11 0.0019
582 DECUBITUS ULCER 15 0.0018
583 INTENTIONAL PRODUCT USE ISSUE 161 0.0018
584 CLOSTRIDIUM DIFFICILE INFECTION 40 0.0018
585 ACUTE HEPATIC FAILURE 25 0.0018
586 ABDOMINAL ABSCESS 8 0.0018
587 LEUKAEMIA 17 0.0018
588 PYREXIA 623 0.0018
589 CYTOKINE RELEASE SYNDROME 36 0.0018
590 GASTROINTESTINAL INFLAMMATION 14 0.0018
591 MENINGITIS ASEPTIC 8 0.0018
592 GASTROENTERITIS 26 0.0018
593 HAEMATURIA 61 0.0018
594 POST PROCEDURAL COMPLICATION 34 0.0018
595 DRUG LEVEL DECREASED 18 0.0018
596 ENDOCARDITIS 9 0.0018
597 LIVER FUNCTION TEST ABNORMAL 51 0.0018
598 LYMPHOMA 27 0.0017
599 WHITE BLOOD CELL COUNT INCREASED 67 0.0017
600 MYOCARDITIS 20 0.0017
601 COAGULOPATHY 29 0.0017
602 PROTEINURIA 33 0.0017
603 PRODUCT USE ISSUE 317 0.0017
604 PLEURISY 10 0.0017
605 STATUS EPILEPTICUS 19 0.0017
606 METASTASIS 12 0.0017
607 GASTRITIS 44 0.0017
608 LIVER INJURY 41 0.0017
609 AUTOIMMUNE DISORDER 16 0.0016
610 LUNG NEOPLASM 7 0.0016
611 UROSEPSIS 15 0.0016
612 ANAEMIA 309 0.0016
613 URINE OUTPUT DECREASED 14 0.0016
614 NEUTROPHIL COUNT DECREASED 64 0.0016
615 RIGHT VENTRICULAR FAILURE 11 0.0016
616 PETIT MAL EPILEPSY 8 0.0016
617 HYPONATRAEMIA 88 0.0016
618 DUODENAL ULCER 11 0.0016
619 DISEASE PROGRESSION 183 0.0015
620 VASCULITIS 18 0.0015
621 DRUG-INDUCED LIVER INJURY 48 0.0015
622 CIRCULATORY COLLAPSE 26 0.0015
623 DERMATITIS BULLOUS 11 0.0015
624 SERUM FERRITIN INCREASED 8 0.0015
625 GRAND MAL CONVULSION 14 0.0015
626 RENAL CYST 12 0.0015
627 ALANINE AMINOTRANSFERASE INCREASED 92 0.0015
628 TYPE 1 DIABETES MELLITUS 9 0.0015
629 GASTROINTESTINAL HAEMORRHAGE 124 0.0015
630 POSTOPERATIVE WOUND INFECTION 10 0.0015
631 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
632 PLATELET COUNT DECREASED 157 0.0015
633 CARDIAC ARREST 121 0.0015
634 HYPERCALCAEMIA 18 0.0015
635 RESPIRATORY DISORDER 43 0.0014
636 LEUKOCYTOSIS 26 0.0014
637 HYPERGLYCAEMIA 52 0.0014
638 SKIN INFECTION 16 0.0014
639 HEPATIC CYTOLYSIS 18 0.0014
640 ACUTE MYELOID LEUKAEMIA 22 0.0014
641 DIALYSIS 20 0.0014
642 HEPATITIS C 17 0.0014
643 TORSADE DE POINTES 11 0.0014
644 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
645 DRUG TOXICITY 19 0.0014
646 CARDIOGENIC SHOCK 20 0.0014
647 DISEASE RECURRENCE 66 0.0014
648 BLOOD URIC ACID INCREASED 8 0.0014
649 HEPATITIS ACUTE 9 0.0014
650 POLYP 9 0.0014
651 MOUTH HAEMORRHAGE 10 0.0014
652 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
653 PNEUMONIA 439 0.0014
654 EPILEPSY 41 0.0013
655 LIVER DISORDER 59 0.0013
656 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
657 HEPATITIS B 8 0.0013
658 HYPOCALCAEMIA 25 0.0013
659 COLITIS ULCERATIVE 59 0.0013
660 NO THERAPEUTIC RESPONSE 16 0.0013
661 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
662 TRANSAMINASES INCREASED 29 0.0013
663 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
664 NEPHROPATHY 12 0.0013
665 ASPARTATE AMINOTRANSFERASE INCREASED 68 0.0013
666 WOUND INFECTION 14 0.0013
667 PAPULE 9 0.0013
668 INFECTION 183 0.0013
669 JAUNDICE 34 0.0013
670 CHOLECYSTITIS 15 0.0013
671 PULMONARY OEDEMA 56 0.0012
672 SKIN LESION 34 0.0012
673 CONDITION AGGRAVATED 375 0.0012
674 CARDIAC FAILURE ACUTE 8 0.0012
675 HAEMOGLOBIN DECREASED 123 0.0012
676 DRUG INEFFECTIVE 1569 0.0012
677 RESPIRATORY TRACT INFECTION 31 0.0012
678 EYELID PTOSIS 12 0.0012
679 WHITE BLOOD CELL COUNT DECREASED 128 0.0012
680 ERYTHEMA MULTIFORME 11 0.0012
681 STEVENS-JOHNSON SYNDROME 26 0.0012
682 ADRENAL INSUFFICIENCY 14 0.0012
683 PULMONARY HYPERTENSION 24 0.0012
684 FOETAL GROWTH RESTRICTION 7 0.0012
685 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
686 PULMONARY FIBROSIS 22 0.0011
687 FOLLICULITIS 12 0.0011
688 PULMONARY CONGESTION 15 0.0011
689 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
690 BLOOD TRIGLYCERIDES INCREASED 20 0.0011
691 PURPURA 10 0.0011
692 HEPATOCELLULAR INJURY 16 0.0011
693 ILEUS 14 0.0011
694 MENTAL STATUS CHANGES 31 0.0011
695 MYELODYSPLASTIC SYNDROME 16 0.0011
696 POLYURIA 9 0.0011
697 MELAENA 24 0.0011
698 MYOCLONUS 13 0.0011
699 PNEUMONIA ASPIRATION 27 0.0011
700 HERPES ZOSTER 62 0.0011
701 PERICARDITIS 18 0.0011
702 SINUS TACHYCARDIA 15 0.0011
703 SMALL INTESTINAL OBSTRUCTION 13 0.0011
704 HEPATOCELLULAR CARCINOMA 8 0.0011
705 PANCREATITIS 55 0.0010
706 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
707 THERAPY PARTIAL RESPONDER 16 0.0010
708 EYE MOVEMENT DISORDER 7 0.0010
709 ECCHYMOSIS 7 0.0010
710 UPPER RESPIRATORY TRACT INFECTION 47 0.0010
711 CARDIOMYOPATHY 15 0.0010
712 ANOREXIA 13 0.0010
713 OESOPHAGITIS 11 0.0010
714 HAEMOPTYSIS 28 0.0010
715 MOUTH ULCERATION 21 0.0010
716 VIRAL INFECTION 33 0.0010
717 PETECHIAE 10 0.0010
718 MUSCLE ATROPHY 12 0.0009
719 ABSCESS 15 0.0009
720 INTRAOCULAR PRESSURE INCREASED 12 0.0009
721 PANCREATITIS ACUTE 21 0.0009
722 DIABETES MELLITUS 71 0.0009
723 ORAL HERPES 18 0.0009
724 CONJUNCTIVITIS 17 0.0009
725 HEPATIC CIRRHOSIS 17 0.0009
726 DRUG ERUPTION 16 0.0009
727 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
728 DELIRIUM 31 0.0009
729 CONVULSION 51 0.0009
730 MYOSITIS 8 0.0009
731 BLINDNESS 36 0.0009
732 URINARY TRACT INFECTION 150 0.0009
733 PULMONARY MASS 13 0.0009
734 HYPOTENSION 175 0.0009
735 GASTROINTESTINAL DISORDER 78 0.0009
736 NEOPLASM 10 0.0009
737 TACHYCARDIA 77 0.0009
738 DRUG INTERACTION 137 0.0009
739 CARDIAC FAILURE 69 0.0009
740 STOMATITIS 52 0.0009
741 HAEMATOCRIT DECREASED 17 0.0009
742 COMA 40 0.0008
743 GENERAL PHYSICAL HEALTH DETERIORATION 96 0.0008
744 PROCEDURAL PAIN 23 0.0008
745 HAEMATEMESIS 21 0.0008
746 FLUID OVERLOAD 12 0.0008
747 ATRIAL FIBRILLATION 80 0.0008
748 HAEMATOCHEZIA 45 0.0008
749 CELLULITIS 41 0.0008
750 BLOOD MAGNESIUM DECREASED 7 0.0008
751 HEPATIC ENZYME INCREASED 55 0.0008
752 NERVOUS SYSTEM DISORDER 25 0.0008
753 BLOOD URINE PRESENT 15 0.0008
754 TOXICITY TO VARIOUS AGENTS 132 0.0008
755 BLINDNESS UNILATERAL 11 0.0008
756 POST PROCEDURAL HAEMORRHAGE 9 0.0008
757 RENAL DISORDER 36 0.0008
758 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
759 SUBDURAL HAEMATOMA 11 0.0008
760 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22 0.0008
761 OXYGEN SATURATION DECREASED 42 0.0007
762 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
763 CARDIOMEGALY 9 0.0007
764 OSTEONECROSIS 24 0.0007
765 SEROTONIN SYNDROME 14 0.0007
766 DIARRHOEA 467 0.0007
767 VISUAL ACUITY REDUCED 24 0.0007
768 INFLAMMATORY BOWEL DISEASE 7 0.0007
769 RASH PAPULAR 16 0.0007
770 FISTULA 8 0.0007
771 BLOOD CALCIUM DECREASED 8 0.0007
772 RASH ERYTHEMATOUS 34 0.0007
773 REBOUND EFFECT 8 0.0007
774 EJECTION FRACTION DECREASED 11 0.0007
775 ABDOMINAL PAIN 162 0.0007
776 APHASIA 21 0.0007
777 DYSURIA 25 0.0007
778 BLOOD POTASSIUM INCREASED 11 0.0007
779 THROMBOSIS 54 0.0007
780 CARDIO-RESPIRATORY ARREST 28 0.0007
781 POLYNEUROPATHY 8 0.0007
782 KIDNEY INFECTION 13 0.0007
783 CEREBRAL INFARCTION 16 0.0007
784 LACTIC ACIDOSIS 21 0.0006
785 CYSTITIS 20 0.0006
786 OEDEMA 34 0.0006
787 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
788 BLOOD PRESSURE FLUCTUATION 15 0.0006
789 PALLOR 17 0.0006
790 GLAUCOMA 12 0.0006
791 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
792 PRESCRIBED OVERDOSE 12 0.0006
793 HYPOKINESIA 9 0.0006
794 UNRESPONSIVE TO STIMULI 16 0.0006
795 IMMUNODEFICIENCY 9 0.0006
796 SKIN DISORDER 20 0.0006
797 RHABDOMYOLYSIS 25 0.0006
798 FULL BLOOD COUNT DECREASED 12 0.0006
799 CONFUSIONAL STATE 96 0.0006
800 OSTEOPENIA 9 0.0006
801 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42 0.0006
802 BODY TEMPERATURE INCREASED 12 0.0006
803 IMPAIRED GASTRIC EMPTYING 8 0.0006
804 INTESTINAL OBSTRUCTION 22 0.0006
805 DIPLOPIA 15 0.0006
806 BLOOD PRESSURE DECREASED 38 0.0006
807 HALLUCINATION, VISUAL 12 0.0006
808 PREMATURE DELIVERY 9 0.0006
809 SEIZURE 65 0.0006
810 DISORIENTATION 22 0.0006
811 HYPOPHAGIA 14 0.0005
812 RECTAL HAEMORRHAGE 23 0.0005
813 OSTEOPOROSIS 22 0.0005
814 PHOTOPHOBIA 10 0.0005
815 IMMUNE SYSTEM DISORDER 7 0.0005
816 PULMONARY EMBOLISM 50 0.0005
817 DYSKINESIA 21 0.0005
818 HYPERTENSION 109 0.0005
819 CHRONIC KIDNEY DISEASE 39 0.0005
820 TREATMENT NONCOMPLIANCE 28 0.0005
821 LABORATORY TEST ABNORMAL 15 0.0005
822 ARRHYTHMIA 24 0.0005
823 HALLUCINATION 38 0.0005
824 VISUAL IMPAIRMENT 61 0.0005
825 RED BLOOD CELL COUNT DECREASED 14 0.0005
826 DYSPHAGIA 46 0.0005
827 VENTRICULAR TACHYCARDIA 8 0.0005
828 HEPATIC STEATOSIS 9 0.0005
829 DEHYDRATION 64 0.0005
830 OEDEMA PERIPHERAL 58 0.0005
831 BRADYCARDIA 25 0.0005
832 MENTAL DISORDER 20 0.0005
833 DIABETIC KETOACIDOSIS 11 0.0005
834 OSTEOMYELITIS 8 0.0004
835 PRODUCTIVE COUGH 21 0.0004
836 RENAL INJURY 13 0.0004
837 RESPIRATORY ARREST 12 0.0004
838 DRUG INTOLERANCE 42 0.0004
839 MUSCLE TWITCHING 10 0.0004
840 WEIGHT DECREASED 121 0.0004
841 BLOOD POTASSIUM DECREASED 13 0.0004
842 BLOOD SODIUM DECREASED 8 0.0004
843 AGITATION 31 0.0004
844 URINARY RETENTION 14 0.0004
845 LIVER FUNCTION TEST INCREASED 9 0.0004
846 AMNESIA 27 0.0004
847 SKIN EXFOLIATION 35 0.0004
848 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
849 COGNITIVE DISORDER 19 0.0004
850 RASH MACULAR 14 0.0004
851 COUGH 112 0.0004
852 CHROMATURIA 9 0.0004
853 PREMATURE BABY 12 0.0004
854 DECREASED APPETITE 92 0.0004
855 IMPAIRED HEALING 13 0.0004
856 INFLUENZA 44 0.0004
857 GOUT 7 0.0004
858 GASTROENTERITIS VIRAL 7 0.0004
859 VOMITING 180 0.0004
860 NEUROPATHY PERIPHERAL 36 0.0004
861 PRODUCT PRESCRIBING ISSUE 8 0.0004
862 MOOD ALTERED 10 0.0004
863 COVID-19 63 0.0004
864 CHILLS 42 0.0004
865 ABDOMINAL PAIN LOWER 9 0.0004
866 ACCIDENTAL OVERDOSE 13 0.0004
867 ABDOMINAL DISTENSION 37 0.0004
868 MUSCULAR WEAKNESS 40 0.0004
869 BONE DENSITY DECREASED 11 0.0004
870 HYPOGLYCAEMIA 17 0.0004
871 ANGINA PECTORIS 10 0.0003
872 HAEMATOMA 9 0.0003
873 INFUSION RELATED REACTION 23 0.0003
874 DYSARTHRIA 13 0.0003
875 JOINT STIFFNESS 9 0.0003
876 NIGHT SWEATS 11 0.0003
877 ACUTE MYOCARDIAL INFARCTION 10 0.0003
878 DEEP VEIN THROMBOSIS 22 0.0003
879 URINARY INCONTINENCE 10 0.0003
880 CHOLELITHIASIS 11 0.0003
881 EPISTAXIS 25 0.0003
882 RASH PRURITIC 18 0.0003
883 RASH 137 0.0003
884 LETHARGY 18 0.0003
885 MOVEMENT DISORDER 10 0.0003
886 SKIN ULCER 8 0.0003
887 PLASMA CELL MYELOMA 12 0.0003
888 ANHEDONIA 8 0.0003
889 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
890 HAEMORRHAGE 31 0.0003
891 ANGIOEDEMA 13 0.0003
892 NEOPLASM PROGRESSION 10 0.0003
893 ASTHENIA 108 0.0003
894 CATARACT 17 0.0003
895 CHEST DISCOMFORT 29 0.0003
896 ERYTHEMA 58 0.0003
897 THERAPEUTIC RESPONSE DECREASED 17 0.0003
898 BLOOD CHOLESTEROL INCREASED 13 0.0003
899 EXPOSURE DURING PREGNANCY 17 0.0003
900 INFLAMMATION 14 0.0003
901 MYALGIA 46 0.0003
902 VISION BLURRED 37 0.0003
903 MATERNAL EXPOSURE DURING PREGNANCY 24 0.0003
904 DYSPNOEA 151 0.0003
905 DYSPNOEA EXERTIONAL 10 0.0003
906 NEPHROLITHIASIS 12 0.0003
907 UNDERDOSE 19 0.0003
908 NO ADVERSE EVENT 46 0.0003
909 ANAPHYLACTIC REACTION 14 0.0003
910 EYE PAIN 14 0.0002
911 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
912 NAUSEA 194 0.0002
913 POLLAKIURIA 10 0.0002
914 BLOOD GLUCOSE INCREASED 45 0.0002
915 CHEST PAIN 44 0.0002
916 FLUID RETENTION 12 0.0002
917 LOSS OF CONSCIOUSNESS 30 0.0002
918 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
919 BRONCHITIS 17 0.0002
920 MUSCULOSKELETAL PAIN 12 0.0002
921 HEART RATE DECREASED 8 0.0002
922 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
923 CONSTIPATION 48 0.0002
924 TINNITUS 10 0.0002
925 RHINORRHOEA 14 0.0002
926 GAIT INABILITY 7 0.0002
927 DEATH 179 0.0002
928 TREMOR 34 0.0002
929 MEDICATION ERROR 11 0.0002
930 LUNG NEOPLASM MALIGNANT 8 0.0002
931 BONE PAIN 11 0.0002
932 MALAISE 81 0.0002
933 DRY EYE 9 0.0002
934 ABDOMINAL DISCOMFORT 30 0.0002
935 SOMNOLENCE 36 0.0002
936 SKIN DISCOLOURATION 8 0.0002
937 BALANCE DISORDER 15 0.0002
938 SLEEP DISORDER 12 0.0002
939 CARDIAC FAILURE CONGESTIVE 13 0.0002
940 DYSGEUSIA 12 0.0002
941 BLISTER 9 0.0002
942 SYNCOPE 16 0.0002
943 OVERDOSE 34 0.0002
944 OROPHARYNGEAL PAIN 14 0.0002
945 IRRITABILITY 9 0.0001
946 VERTIGO 9 0.0001
947 HYPOAESTHESIA 22 0.0001
948 HEADACHE 92 0.0001
949 SINUSITIS 15 0.0001
950 INFLUENZA LIKE ILLNESS 12 0.0001
951 INJURY 10 0.0001
952 EMOTIONAL DISTRESS 17 0.0001
953 CEREBROVASCULAR ACCIDENT 23 0.0001
954 WHEEZING 8 0.0001
955 DRY SKIN 18 0.0001
956 DYSPEPSIA 13 0.0001
957 HYPERSENSITIVITY 24 0.0001
958 PAIN IN EXTREMITY 38 0.0001
959 MOBILITY DECREASED 9 0.0001
960 NASOPHARYNGITIS 23 0.0001
961 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
962 HEART RATE INCREASED 12 0.0001
963 PARAESTHESIA 19 0.0001
964 MEMORY IMPAIRMENT 16 0.0001
965 DEPRESSION 26 0.0001
966 ABDOMINAL PAIN UPPER 23 0.0001
967 WEIGHT INCREASED 24 0.0001
968 SWELLING 10 0.0001
969 FALL 35 0.0001
970 BACK PAIN 24 0.0001
971 MUSCULOSKELETAL STIFFNESS 9 0.0001
972 GAIT DISTURBANCE 19 0.0001
973 DIZZINESS 49 0.0001
974 BLOOD PRESSURE INCREASED 15 0.0001
975 PAIN 60 0.0001
976 INSOMNIA 26 0.0001
977 FATIGUE 74 0.0001
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
979 INTENTIONAL PRODUCT MISUSE 8 0.0001
980 MYOCARDIAL INFARCTION 15 0.0001
981 HYPERHIDROSIS 11 0.0001
982 PALPITATIONS 10 0.0001
983 PRURITUS 32 0.0001
984 ARTHRALGIA 34 0.0001
985 PERIPHERAL SWELLING 12 0.0001
986 CARDIAC DISORDER 7 0.0001
987 JOINT SWELLING 9 0.0001
988 URTICARIA 11 0.0001
989 ANXIETY 18 0.0001
990 ASTHMA 7 0.0001
991 ALOPECIA 11 0.0001
992 HOSPITALISATION 8 0.0001
993 INCORRECT DOSE ADMINISTERED 8 0.0000